secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001558370-22-018762
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema Pharmaceuticals amends bylaws to update stockholder nomination procedures
-------------------------------------------------------------------------------

- Board approved amended and restated bylaws effective December 15, 2022.
- Revisions address Rule 14a-19 universal proxy rules and update director nomination information requirements.
- Updated provisions on conduct of stockholder meetings and setting date, time, place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000155837022018762/0001558370-22-018762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000155837022018762/olma-20221215x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer